Psomagen, Inc. expands its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services. These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology from 10x Genomics, a life science technology company building products to interrogate, understand, and master biology. SCS is being used to help scientists better understand the mechanisms of infection and immune response at the level of an individual cell. That knowledge is important because it helps learn how to better prevent and treat diseases like COVID-19, cancer, Alzheimer’s, and more. Psomagen’s SCS team is building on the company’s long-standing genomics expertise, handling the entire study workflow for its clients — from sample clean up and quality control to library preparation, sequencing, and analysis of complex cell populations. In less than three weeks, Psomagen’s clients have results and the detailed molecular insights they need to answer even the most complicated research questions.